An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines

Abstract The role of the enzyme hexokinase 2 in many cancers has been identified through increased glycolysis or binding to the pro-apoptotic channel located in the outer mitochondrial membrane, (VDCA1) and protein kinase (MTOR). To prevent the cancer-causing pathways of this enzyme, it is possible...

Full description

Saved in:
Bibliographic Details
Main Authors: Faranak Karamifard, Ali Dadbinpour, Mahta Mazaheri
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-94858-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850063522870853632
author Faranak Karamifard
Ali Dadbinpour
Mahta Mazaheri
author_facet Faranak Karamifard
Ali Dadbinpour
Mahta Mazaheri
author_sort Faranak Karamifard
collection DOAJ
description Abstract The role of the enzyme hexokinase 2 in many cancers has been identified through increased glycolysis or binding to the pro-apoptotic channel located in the outer mitochondrial membrane, (VDCA1) and protein kinase (MTOR). To prevent the cancer-causing pathways of this enzyme, it is possible to disrupt the interaction of hexokinase subunits. Peptides can be utilized to interfere with the interaction of subunits by binding to amino acids that contribute to enzyme dimerization. Nowadays, peptides have become a suitable option for the treatment of various diseases, especially cancer, due to their small size, ease of synthesis, and ability to penetrate the tumor. This study examined the toxic effect of peptides that inhibit enzyme interaction on tumorigenic MCF-7 and MDA-MB-231 and non-tumorigenic MCF10A cell lines through MTT analysis and flow cytometry to determine cell apoptosis. The MCF-7 line experienced a significant decrease in cell proliferation with both peptides. The RYALFSS peptide caused a decrease in the number of MDA-MB-231 cells, but the EKGLGATTHPTAAVKML peptide caused a significant increase. There was no significant increase or decrease in the MCF10A cell line. The study’s finding indicate that peptides can serve as a tool to prevent the proliferation of carcinogenic cells.
format Article
id doaj-art-317eb49352e04a4b92ff74a9f5b183e0
institution DOAJ
issn 2045-2322
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-317eb49352e04a4b92ff74a9f5b183e02025-08-20T02:49:34ZengNature PortfolioScientific Reports2045-23222025-03-0115111610.1038/s41598-025-94858-6An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell linesFaranak Karamifard0Ali Dadbinpour1Mahta Mazaheri2Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical SciencesDepartment of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical SciencesDepartment of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical SciencesAbstract The role of the enzyme hexokinase 2 in many cancers has been identified through increased glycolysis or binding to the pro-apoptotic channel located in the outer mitochondrial membrane, (VDCA1) and protein kinase (MTOR). To prevent the cancer-causing pathways of this enzyme, it is possible to disrupt the interaction of hexokinase subunits. Peptides can be utilized to interfere with the interaction of subunits by binding to amino acids that contribute to enzyme dimerization. Nowadays, peptides have become a suitable option for the treatment of various diseases, especially cancer, due to their small size, ease of synthesis, and ability to penetrate the tumor. This study examined the toxic effect of peptides that inhibit enzyme interaction on tumorigenic MCF-7 and MDA-MB-231 and non-tumorigenic MCF10A cell lines through MTT analysis and flow cytometry to determine cell apoptosis. The MCF-7 line experienced a significant decrease in cell proliferation with both peptides. The RYALFSS peptide caused a decrease in the number of MDA-MB-231 cells, but the EKGLGATTHPTAAVKML peptide caused a significant increase. There was no significant increase or decrease in the MCF10A cell line. The study’s finding indicate that peptides can serve as a tool to prevent the proliferation of carcinogenic cells.https://doi.org/10.1038/s41598-025-94858-6Hexokinase II enzymeInhibitory peptidesGlycolysisCell lines
spellingShingle Faranak Karamifard
Ali Dadbinpour
Mahta Mazaheri
An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
Scientific Reports
Hexokinase II enzyme
Inhibitory peptides
Glycolysis
Cell lines
title An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
title_full An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
title_fullStr An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
title_full_unstemmed An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
title_short An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines
title_sort in vitro measurement for the toxicity of peptides inhibit hexokinase ii in breast cancer cell lines
topic Hexokinase II enzyme
Inhibitory peptides
Glycolysis
Cell lines
url https://doi.org/10.1038/s41598-025-94858-6
work_keys_str_mv AT faranakkaramifard aninvitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines
AT alidadbinpour aninvitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines
AT mahtamazaheri aninvitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines
AT faranakkaramifard invitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines
AT alidadbinpour invitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines
AT mahtamazaheri invitromeasurementforthetoxicityofpeptidesinhibithexokinaseiiinbreastcancercelllines